Bioservo Technologies AB (publ) Stock Nasdaq Stockholm
Equities
BIOS
SE0009779085
Advanced Medical Equipment & Technology
Sales 2021 | 10.53M 962K 1.32M | Sales 2022 | 13.76M 1.26M 1.72M | Capitalization | 47.84M 4.37M 5.98M |
---|---|---|---|---|---|
Net income 2021 | -34M -3.11M -4.25M | Net income 2022 | -50M -4.57M -6.25M | EV / Sales 2021 | 12.2 x |
Net cash position 2021 | 51.52M 4.71M 6.44M | Net cash position 2022 | 25.01M 2.29M 3.13M | EV / Sales 2022 | 1.66 x |
P/E ratio 2021 |
-4.55
x | P/E ratio 2022 |
-0.66
x | Employees | 20 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.03% |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |